CEO, Founder | Lisa Sakashita

M. S. degree from department of Physics, the University of Tokyo. B. S. degree from department of Physics, Tokyo University of Science. Her career includes positions at Nomura Securities, Co., Ltd. (analyst, Investment Banking division.), Bloomberg LLP (data analyst), Ginza Galleries (International Public Relations/Overseas Project Integration) and Linkers Corporation (Managing Executive Officer). At Linkers Corporation, a start-up company in the technology matching service , she won MVP for top sales.

CTO | Jinsei Miyazaki

B. E., and M. E. degree from Faculty of Technology, Kyoto University.
Guest scientist of Max-Planck Institute of Bio-Physical Chemistry during 1989-1991.
In 1981, he joined Matsushita Electric Industries (now Known as Panasonic) and has since been instrumental in advancing new technologies, including immuno-chemical sensing. In 2002, he founded Viterion LLC, in NY USA, a joint venture focused on telehealth, and served as CTO. After returning to Japan in 2006, he led R&D and regulatory approval processes of various medical devices as Technical Department Head at  Panasonic Healthcare Co. Ltd. until his move to Meiji Seika Pharma in 2015, where he engaged in the development of Photodynamic therapy, a laster technology targeting cancer. Aligning with Nanotis'mission focusing on easy disease detection, he took on the role of CTO starting in 2019.

Director of Corporate Strategy | Hajime Seki Ph.D.,MBA

MBA from HEC Paris, Ph.D. in Chemistry from University of Minnesota, B.S. in Chemistry from Keio University. Upon receiving his degree in the U.S., he worked in chemical biology at The Scripps Research Institute. He then returned to Japan and engaged in drug discovery research at a pharmaceutical company. His interest in business led him to obtain an MBA in France, after which he joined a consulting firm, where he led projects such as opportunity assessment, market research, and licensing for global pharmaceutical and medical device companies. Drawn by the societal impact and technological promise, he became a part of Nanotis corporation in 2023.

Technology Director | Naoyuki Sekioka Ph.D.

Ph.D. degree from Pure and Applied Sciences, University of Tsukuba. Visiting Researcher, Nihon University during 2012-2018. In 2009, he joined a manufacturer specializing in clinical laboratory analyzers and worked on the development of  biosensors and related equipment. In 2021, he became the development group leader and continued to oversee new product development of clinical laboratory analyzers. He resonated with Nanotis' vision of achieving highly-sensitive and rapid testing, and in 2022, he joined as a Technology Director.

Member of the Board | Toshiaki Masuda

Managing Director of Nipro Corporation  Medical Technology Division for Planning,Development & Marketing; Research &Development Center

He joined Nipro Corporation in 1975 and stepped into his current position in 2022 after working as General Manager of Dialysis Product Sales Department, General Manager of Product Development Sales Department, Managing Director, and General Manager of Research Institute.

Scientific Founder | Michika Onoda Ph.D.

Dr. Michika Onoda is a Postdoctoral Researcher at Massachusetts Institute of Technology.

He received a Ph. D. degree from faculty of Materials Engineering, the University of Tokyo (Top Graduate, President's Award). His career includes JSPS Research Fellow DC1 (2016), Visiting Researcher at University of Minnesota (2017), JSPS Superlative Postdoctoral Fellow at Nagoya University (2019 to present), and Postdoctoral Researcher at Massachusetts Institute of Technology (2019 to present).

The target of his research is to create novel functional polymeric materials, especially in the field of the polymer gel. In his career, he won more than eighteen awards at national and international conferences including the University of Tokyo President's Award for the outstanding research about artificial amoeba utilizing polymeric fluids. In addition to his research, he established science media and works as a writer collaborating with 2Dfacto, Inc.

Technical Advisor | Teruyuki Nagamune Ph.D.

B. S., M. S., and Ph. D. degree from school of Chemical Engineering, Tokyo Institute of Technology in 1973, 1975, and 1985. His career includes positions at RIKEN (Research Scientist from 1977), University of Illinois (Visiting Researcher from 1988), RIKEN (Vice Senior Research Scientist from 1992), the University of Tokyo (Professor from 1993). Dr. Nagamune is the winner of the 25th Ichimura Award (1993), The SCEJ Award (Tamaki Medal) (2002), Ichimura Prize, IUPAC Fellow on Biotechnology, The SCEJ Award (Ikeda Medal) (2014), among others.

Collaborator | Yoshida-Akimoto lab., the Univ. of Tokyo

The target of the research group is to create novel bio-inspired materials exhibiting dynamic properties inspired by self-organized biomimetic characters of living organisms.
Yoshida-Akimoto lab. Home Page

Ryo Yoshida, Ph. D.

Dr. Ryo Yoshida is a full professor at The University of Tokyo. He received his Ph.D. degree in chemical engineering in 1993 from Waseda University, Japan. He was a research associate at Tokyo Women’s Medical University in 1993, a researcher at the National Institute of Materials and Chemical Research from 1994–1997, and an assistant professor at University of Tsukuba from 1997–2000. In 2001, he moved to The University of Tokyo as an associate professor and became a full professor in 2012. He won the Society of Polymer Science, Japan Wiley Award in 2009.

Collaborator | Norio Omagari  M.D., M.Sc., Ph.D.

Disease Control and Prevention Center
Director

Dr. Norio Omagari graduated from Saga Medical School’s Faculty of Medicine, Saga University in 1997.
In the same year, he joined St. Luke's International Hospital as a resident, and then became a general internal medicine staff member. Thereafter, he joined Aida Memorial Hospital in 2001 and the Division of Infectious Diseases at the University of Texas-Houston Medical School in 2002. From 2004 to 2010, he assumed the position from  Senior Staff to Chief in the Division of Infectious Diseases at Shizuoka Cancer Center.
He joined the National Center for Global Health and Medicine and has been the center’s director since 2012.
In 2015, he earned an M.D. in clinical infectious diseases from the Graduate School of Medicine, Aichi Medical University.